Tangier disease and ABCA1

被引:180
作者
Oram, JF [1 ]
机构
[1] Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2000年 / 1529卷 / 1-3期
关键词
Tangier disease; adenosine 5 '-triphosphate binding cassette transporter A1; adenosine 5'-triphosphate binding cassette; transporter; 1; cholesterol efflux; apolipoprotein; high-density lipoprotein; atherosclerosis;
D O I
10.1016/S1388-1981(00)00157-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tangier disease is an autosomal recessive genetic disorder characterized by a severe high-density lipoprotein (HDL) deficiency, sterol deposition in tissue macrophages, and prevalent atherosclerosis. Mutations in the ATP binding cassette transporter ABCA1 cause Tangier disease and other familial HDL deficiencies. ABCA1 controls a cellular pathway that secretes cholesterol and phospholipids to lipid-poor apolipoproteins. This implies that an inability of newly synthesized apolipoproteins to acquire cellular lipids by the ABCA1 pathway leads to their rapid degradation and an over-accumulation of cholesterol in macrophages. Thus, ABCA1 plays a critical role in modulating flux of tissue cholesterol and phospholipids into the reverse cholesterol transport pathway, making it an important therapeutic target for clearing excess cholesterol from macrophages and preventing atherosclerosis, (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:321 / 330
页数:10
相关论文
共 61 条
  • [1] Assmann G, 1995, METABOLIC MOL BASES, P2053
  • [2] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
    Bodzioch, M
    Orsó, E
    Klucken, T
    Langmann, T
    Böttcher, L
    Diederich, W
    Drobnik, W
    Barlage, S
    Büchler, C
    Porsch-Özcürümez, M
    Kaminski, WE
    Hahmann, HW
    Oette, K
    Rothe, G
    Aslanidis, C
    Lackner, KJ
    Schmitz, G
    [J]. NATURE GENETICS, 1999, 22 (04) : 347 - 351
  • [3] BORTNICK AE, 2000, IN PRESS J BIOL CHEM
  • [4] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [5] Brousseau ME, 2000, J LIPID RES, V41, P1125
  • [6] Brousseau ME, 2000, J LIPID RES, V41, P433
  • [7] COSTET P, 2000, IN PRESS J BIOL CHEM
  • [8] Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression - Visualization by electron microscopy
    Crawford, AR
    Smith, AJ
    Hatch, VC
    Elferink, RPJO
    Borst, P
    Crawford, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) : 2562 - 2567
  • [9] Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients
    Drobnik, W
    Liebisch, G
    Biederer, C
    Trümbach, B
    Rogler, G
    Müller, P
    Schmitz, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (01) : 28 - 38
  • [10] ACTIVATION OF PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-C IN RESPONSE TO HDL(3) AND LDL IS MARKEDLY REDUCED IN CULTURED FIBROBLASTS FROM TANGIER PATIENTS
    DROBNIK, W
    MOLLERS, C
    RESINK, T
    SCHMITZ, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) : 1369 - 1377